Xiaofei Zhou
Impact in
- Immunology top 2%
- Immune Cell Function and Interaction
- Immune cells in cancer
- T-cell and B-cell Immunology
- interferon and immune responses
- Immune Response and Inflammation
- Cancer Research top 2%
- NF-κB Signaling Pathways
- Cancer, Hypoxia, and Metabolism
Papers in
- Immunology 36
- Immune Cell Function and Interaction 18
- Immunotherapy and Immune Responses 8
- interferon and immune responses 6
- Immune cells in cancer 6
-
- Ubiquitin and proteasome pathways 9
- Co-authors
- Shao‐Cong Sun (27 shared papers)Xuhong Cheng (23 shared papers)Yichuan Xiao (9 shared papers)Jae‐Hoon Chang (6 shared papers)Mikyoung Chang (6 shared papers)Mako Nakaya (5 shared papers)Marzenna Blonska (1 shared paper)Xin Lin (1 shared paper)
- Journals
- Nature Immunology (7 papers)Cancer Research (4 papers)Nature Communications (4 papers)World Neurosurgery (4 papers)PLoS ONE (3 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Xiaofei Zhou
93 papers receiving 3.4k citations
Xiaofei Zhou's Hit Papers
Peers
Comparison fields: 5 of 138
- Immunology 1.3k
- Cancer Research 695
- Oncology 705
- Molecular Biology 1.4k
- Biological Psychiatry 46
Countries citing papers authored by Xiaofei Zhou
This map shows the geographic impact of Xiaofei Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofei Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofei Zhou more than expected).
Fields of papers citing papers by Xiaofei Zhou
This network shows the impact of papers produced by Xiaofei Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofei Zhou. The network helps show where Xiaofei Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaofei Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 102 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inflammatory T Cell Responses Rely on Amino Acid Transporter ASCT2 Facilitation of Glutamine Uptake and mTORC1 Kinase Activation Hit paper breakdown → | 2014 | 679 |
| 2 | 2014 | 205 | |
| 3 | 2013 | 152 | |
| 4 | 2011 | 148 | |
| 5 | 2012 | 117 | |
| 6 | 2020 | 99 | |
| 7 | 2015 | 94 | |
| 8 | 2013 | 94 | |
| 9 | 2021 | 87 | |
| 10 | 2019 | 80 | |
| 11 | 2009 | 79 | |
| 12 | 2004 | 65 | |
| 13 | 2019 | 63 | |
| 14 | 2014 | 59 | |
| 15 | 2021 | 58 | |
| 16 | 2017 | 55 | |
| 17 | 2016 | 54 | |
| 18 | 2022 | 53 | |
| 19 | 2017 | 51 | |
| 20 | 2013 | 49 |
About Xiaofei Zhou
Xiaofei Zhou is a scholar working on Immunology, Molecular Biology, Oncology, Cancer Research and Epidemiology, having authored 102 papers that have together received 3.5k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (18 papers), Ubiquitin and proteasome pathways (9 papers), Immunotherapy and Immune Responses (8 papers), NF-κB Signaling Pathways (8 papers), interferon and immune responses (6 papers), Autophagy in Disease and Therapy (6 papers), Immune cells in cancer (6 papers) and CAR-T cell therapy research (6 papers). The work is most often cited by research in Immunology (1.3k citations), Cancer Research (695 citations), Oncology (705 citations), Molecular Biology (1.4k citations) and Biological Psychiatry (46 citations). Xiaofei Zhou has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Shao‐Cong Sun, Xuhong Cheng, Yichuan Xiao, Jae‐Hoon Chang, Mikyoung Chang, Mako Nakaya, Marzenna Blonska, Xin Lin, Hongbo Hu and Jin Jin. Their work appears in journals such as Nature Immunology, Cancer Research, Nature Communications, World Neurosurgery and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.